Keyphrases
Antiretroviral Therapy
42%
AIDS/HIV
37%
Confidence Interval
35%
Lymphatic Filariasis
29%
People Living with HIV (PLHIV)
28%
Risk Factors
24%
HIV Patients
22%
Nigeria
21%
Hypertension
21%
Microfilaria
20%
Mass Drug Administration
20%
HIV Care
19%
COVID-19
18%
Cardiovascular Disease
16%
Brugia Malayi
16%
Albendazole
15%
United States
15%
Low-middle Income Countries
15%
Randomized Controlled Trial
15%
Kenya
15%
Diethylcarbamazine
14%
Ivermectin
14%
Zambia
14%
Hypertension Management
14%
India
13%
Sub-Saharan Africa
13%
Wuchereria Bancrofti
13%
Surgical Site Infection
13%
Blood Pressure
12%
Odds Ratio
12%
Filariasis
12%
Filarial
11%
Bancroftian Filariasis
11%
Onchocerciasis
11%
Onchocerca Volvulus
11%
Heart Failure
11%
Uganda
11%
HIV Infection
10%
Healthcare Workers
10%
Africa
10%
Human Immunodeficiency Virus Type 1 (HIV-1)
10%
Intensive Care Unit
9%
Clinical Trials
9%
Infection Rate
9%
CD4 Count
9%
Cluster Randomized Trial
9%
Household Air Pollution
9%
Ghana
9%
Implementation Science
9%
Antigenemia
8%
Cardiovascular Risk
8%
World Health Organization
8%
Fluconazole
8%
Left Ventricular Function
8%
Meta-analysis
8%
Microfilaraemia
8%
St. Louis
8%
Older Adults
8%
Antiretroviral Therapy Initiation
7%
HIV Treatment
7%
Cardiac Surgery
7%
Tertiary Care Hospital
7%
Adjusted Odds Ratio
7%
High Risk
7%
Wolbachia
7%
Adverse Events
7%
Bloodstream Infection
7%
Epidemiology
7%
Amphotericin B
7%
Clinical Outcomes
7%
Tuberculosis
6%
Human Immunodeficiency Virus Infection
6%
HIV Testing
6%
Missouri
6%
Peru
6%
Pregnant Women
6%
Worm
6%
Clostridium Difficile Infection
6%
Highly Active Antiretroviral Therapy (HAART)
6%
Parasite Antigens
6%
HIV Self-testing (HIVST)
6%
Opportunistic Infections
6%
Randomized Trial
6%
Latin America (LATAM)
6%
Cardiovascular Prevention
6%
Filarial Parasites
6%
Heart Failure with Preserved Ejection Fraction (HFpEF)
6%
Filarial Nematodes
6%
Quantitative PCR
6%
Liquefied Petroleum Gas
5%
Implementation Research
5%
Adult Worm
5%
Systolic Blood Pressure
5%
Cardiovascular Health
5%
Cryptococcal Meningitis
5%
Ventilator-associated Pneumonia
5%
Placebo
5%
Diabetes
5%
Retention in Care
5%
Viral Suppression
5%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Antiretroviral Therapy
30%
Infection
28%
Diseases
25%
Lymphatic Filariasis
23%
Cardiovascular Disease
23%
Prevalence
23%
Cardiovascular System
18%
COVID-19
17%
Drug Administration
14%
Congestive Heart Failure
14%
Randomized Controlled Trial
13%
Blood Pressure
13%
Health Care Cost
12%
Systematic Review
12%
Odds Ratio
12%
Low and Middle Income Countries
11%
Surgical Infection
11%
Apoplexy
11%
Cross Sectional Study
11%
Albendazole
10%
Ivermectin
10%
Human Immunodeficiency Virus Infection
10%
Onchocerciasis
9%
Public Health
9%
Intensive Care Unit
9%
Clinical Trial
9%
Primary Health Care
8%
Diethylcarbamazine
8%
Household
8%
Adolescence
8%
Diabetes
7%
Cohort Effect
7%
Adverse Event
7%
Cohort Analysis
7%
Health Care
7%
Diagnosis
7%
Bloodstream Infection
7%
Pediatrics
7%
Onchocerca volvulus
6%
Meta-Analysis
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Tertiary Care
6%
Clinician
6%
HIV Test
6%
Combination Therapy
6%
Atherosclerosis
5%
Heart Surgery
5%
Wuchereria bancrofti
5%
Myocardial Infarction
5%
Quality Improvement
5%
Filariasis
5%
Brugia malayi
5%
Medicine
5%
Alzheimer's Disease
5%
Bancroftian Filariasis
5%
Placebo
5%
Cluster Randomized Trial
5%
Hazard Ratio
5%
Community Health
5%
Polypill
5%
Health System
5%